- Home
- LGVN vs ALUR Comparison
LGVN vs ALUR Comparison
Compare LGVN & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- ALUR
- Stock Information
- Founded
- LGVN 2014
- ALUR 2009
- Country
- LGVN United States
- ALUR United States
- Employees
- LGVN N/A
- ALUR N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- ALUR
- Sector
- LGVN Health Care
- ALUR
- Exchange
- LGVN Nasdaq
- ALUR Nasdaq
- Market Cap
- LGVN 16.6M
- ALUR 16.8M
- IPO Year
- LGVN 2021
- ALUR N/A
- Fundamental
- Price
- LGVN $0.79
- ALUR $2.14
- Analyst Decision
- LGVN Strong Buy
- ALUR Strong Buy
- Analyst Count
- LGVN 2
- ALUR 3
- Target Price
- LGVN $6.50
- ALUR $22.83
- AVG Volume (30 Days)
- LGVN 496.8K
- ALUR 53.1K
- Earning Date
- LGVN 11-11-2025
- ALUR 11-12-2025
- Dividend Yield
- LGVN N/A
- ALUR N/A
- EPS Growth
- LGVN N/A
- ALUR N/A
- EPS
- LGVN N/A
- ALUR N/A
- Revenue
- LGVN $2,073,000.00
- ALUR $19,917,000.00
- Revenue This Year
- LGVN N/A
- ALUR N/A
- Revenue Next Year
- LGVN N/A
- ALUR $168.27
- P/E Ratio
- LGVN N/A
- ALUR N/A
- Revenue Growth
- LGVN 68.67
- ALUR N/A
- 52 Week Low
- LGVN $0.63
- ALUR $1.98
- 52 Week High
- LGVN $2.48
- ALUR $20.00
- Technical
- Relative Strength Index (RSI)
- LGVN 37.95
- ALUR 40.16
- Support Level
- LGVN $0.78
- ALUR $2.10
- Resistance Level
- LGVN $0.85
- ALUR $2.22
- Average True Range (ATR)
- LGVN 0.05
- ALUR 0.11
- MACD
- LGVN 0.02
- ALUR 0.02
- Stochastic Oscillator
- LGVN 46.30
- ALUR 40.74
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.